For the weight management indication, the general requirement is a BMI of 30 or above, or 27 or above with at least one weight-related comorbidity
GLP-1R agonists represent a mainstay of diabetes therapy, but over the last decade there has been increasing evidence that this class of drug may also be of use in Parkinsons
doi:10.1056/NEJMoa1603827 8
507 The brains of individuals with preclinical AD (PCAD) and AD exhibit oxidative damage to a variety of molecules, e.g., accumulation of protein carbonyls (PCs) in regions that are rich in A-peptide-containing SPs, increased lipid peroxidation in AD and PCAD hippocampi and elevated DNA damage
30 seconds after moistening the test strip with fresh urine, its color provides information indicative of a possible deficit of ascorbic acid in the urine
Lipo-C Overview Lipo-C is a compounded lipotropic injection